MetLife Investment Management, LLC - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q3 2019$128,091
-19.5%
26,1410.0%0.00%
-50.0%
Q2 2019$159,199
+4.8%
26,1410.0%0.00%0.0%
Q1 2019$151,879
-56.8%
26,1410.0%0.00%
-50.0%
Q4 2018$351,858
-30.7%
26,1410.0%0.00%
-20.0%
Q3 2018$507,397
-24.0%
26,1410.0%0.01%
-37.5%
Q2 2018$668,000
+48.4%
26,141
+17.2%
0.01%
+60.0%
Q1 2018$450,000
+0.4%
22,3080.0%0.01%0.0%
Q4 2017$448,00022,3080.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q1 2018
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders